Inhibition of FcRn with rozanolixizumab in adults with immune thrombocytopenia: Two randomised, double‐blind, placebo‐controlled phase 3 studies and their open‐label extension

Documenti analoghi

• Immune thrombocytopenia (ITP) in pregnancy
  di: James B. Bussel, et al.
  Pubblicazione: (2024)
• The paradox of autoimmune thrombocytopenia in common variable immunodeficiency
  di: Brit Trogen, et al.
  Pubblicazione: (2025)
• Cognitive impairment among patients with chronic immune thrombocytopenia
  di: David J. Kuter, et al.
  Pubblicazione: (2024)
• Fetal–neonatal alloimmune thrombocytopenia: Mothers are affected too
  di: Eleanore A. McFarland, et al.
  Pubblicazione: (2025)
• Increased risk of haematological malignancy in adults over age 60 with thrombocytopenia compared with matched controls: Time for an upfront bone marrow evaluation?
  di: A. Vijenthira, et al.
  Pubblicazione: (2024)